Pharmaron’s Coventry facility in Rhode Island is a fully FDA- and DEA-approved cGMP site specializing in commercial-scale API (Active Pharmaceutical Ingredients) synthesis. Equipped with reactors ranging from 50 L to 8,000 L and a combined capacity of approximately 76,000 L, the site supports development from clinical-scale through multi-ton production. With extensive hydrogenation capabilities and a hybrid China–US model for cost-efficient supply chains, Pharmaron Coventry provides full development and manufacturing services for pharmaceutical and biotech partners.
Customers generally enjoyed the food, noting it was fresh and tasty, although there were some complaints about specific items being cold or not prepared correctly.
Customer Service
Service quality was inconsistent; while some staff were praised for being friendly and helpful, others were reported as rude or indifferent.
Cleanliness
The restaurant was frequently described as clean, with positive remarks about the overall hygiene and condition of the facility.
Coupon Issues
Several customers expressed frustration over the refusal to accept coupons and issues with online orders, leading to dissatisfaction.
Operational Hours
There were complaints about unclear operational hours and being turned away before closing time.